Fig 1: Effects of AGE-treated EVs-MSC on the expression of glucose transporters and metabolic enzymes in HUVECs. (a–d) mRNA levels of (a) GLUT1, (b) GLUT3, (c) GLUT4, and (d) SCO2 in HUVECs. (e) Western blot images showing protein levels of GLUT1, GLUT3, GLUT4, and SCO2 in HUVECs. (f) Quantification of protein levels of GLUT1, GLUT3, GLUT4, and SCO2 in HUVECs, normalized to actin. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001. AGEs, advanced glycation end products; EVs, extracellular vesicles; GLUT; glucose transporter type; HUVEC, human umbilical vein endothelial cells; MSC, mesenchymal stem cells; SCO2, synthesis of cytochrome c oxidase 2.
Supplier Page from Abcam for Anti-SCO2 antibody